StockData

Black Hawk Acquisition Corp (BKHA) stock

BKHANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends November 30Also trades as BKHAR, BKHAU
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 6, 2026Score 5/30
$8.65+1.45 (+20.14%)

Close on Nov 17, 2026Market cap $35.93MP/E –Yield –

Black Hawk Acquisition price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

No price to sales ratio figures for Black Hawk Acquisition

Black Hawk Acquisition has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Black Hawk Acquisition figures

See a number that looks wrong?